240
Participants
Start Date
January 1, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2026
ancetate gel
An acetic acid thermoreversible gel produced by Shanghai Jinxiang Latex Products Co. will be utilized for the intervention. Each product weighs 4.85 g and contains 54.45 mg of poloxamer 407-acetic acid. The investigators will stockpile the product and distribute a total of 72 doses on the first day, at the end of the second month, and at the end of the fourth month of follow-up, respectively, after concealing the product's name. Participants will receive instructions to apply the medication transvaginally, one dose at a time, during each instance of sexual activity.
nonoxinol gel
The nonoxinol gel produced by China Pharmaceutical University Pharmacy Co., Ltd will be utilized for the intervention. Each product weighs 5 g and contains 50 mg of N-9. The investigators will stockpile the product and distribute a total of 72 doses on the first day, at the end of the second month, and at the end of the fourth month of follow-up, respectively, after concealing the product's name. Participants will receive instructions to apply the medication transvaginally, one dose at a time, during each instance of sexual activity.
Beijing Shijitan Hospital, Capital Medical University, Beijing
The Obstetrics & Gynecology Hospital of Fudan University, Shanghai
Tianjin Central Hospital of Gynecology Obstetrics, Tianjin
The Second Hospital of Hebei Medical University, Shijiazhuang
Shanghai Jinxiang Latex Products Co.
UNKNOWN
National Research Institute for Family Planning, China
OTHER_GOV